Results 71 to 80 of about 7,148 (201)

Novel targets in headache: A narrative review

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background This narrative review summarizes novel applications for the use of calcitonin gene‐related peptide (CGRP)‐targeted therapies that go beyond migraine, the latest updates with respect to targeting pituitary adenylate cyclase‐activating peptide (PACAP) as therapeutic in migraine, as well as exploring other more recently ...
Adriana Della Pietra, Peter J. Goadsby, Carolina Oldoni, Stephen Silberstein, Fred Cohen, Simon Akerman   +5 more
wiley   +1 more source

Alloparenting the investment child: A reply to responses

The British Journal of Sociology, EarlyView.
Nina Bandelj
wiley   +1 more source

Headache disorders among Indigenous communities: A scoping review undertaken with knowledge keeper guidance

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective We performed a scoping review of literature on headache etiology, classification, prevalence, and treatment in Indigenous communities in Canada, the United States, Australia, and New Zealand. Background In the United States, analysis of national prevalence indicates that Indigenous Americans lead all other racial/ethnic groups in ...
Maia Kelly, Candice M. Todd, Ojistoh Kahnawahere Horn, Emily Simmonds, Diane Longboat, Cynthia White, Suvendrini Lena   +6 more
wiley   +1 more source

Opioid use, disability, and patient‐reported cognitive impairment in migraine: Multi‐country results from the Chronic Migraine Epidemiology and Outcomes—International Study

Headache: The Journal of Head and Face Pain, EarlyView.
Plain Language Summary Opioids are widely used to treat migraine despite being contrary to clinical guidelines. In the Chronic Migraine Epidemiology and Outcomes–International (CaMEO‐I) Study, a large, international survey of people with migraine, opioid users were more likely than nonusers to experience moderate or severe migraine‐related disability ...
Elizabeth Leroux, Dawn C. Buse, Michel Lanteri‐Minet, Fumihiko Sakai, Manjit Matharu, Zaza Katsarava, Kristina M. Fanning, Karen Carr, Nicole Naccara, Janette Contreras‐De Lama, Richard B. Lipton   +10 more
wiley   +1 more source

A ‘Black Diamond’, But Not a ‘Silver Bullet’: Oral Health Professionals' Perception of SDF Use in New Zealand—A Qualitative Study

International Journal of Dental Hygiene, EarlyView.
ABSTRACT Introduction Despite the free childhood dental care in New Zealand (NZ), the need for extensive dental treatment, particularly hospital dental treatment is on the rise. This study aimed to explore the perspectives of oral health professionals and cariology experts on the use of silver diamine fluoride (SDF) in reducing outpatient dental ...
Batool Ghashi, Hanna Olson, Zeina Al Naasan   +2 more
wiley   +1 more source

Patients', Relatives' and Healthcare Professionals' Experiences and Perceptions of Raising Concerns About Acute Deterioration: A Qualitative Case Study

Journal of Advanced Nursing, EarlyView.
ABSTRACT Aim To explore adult patients', relatives', and healthcare professionals' experiences of acute deterioration and perceptions of patient/family involvement in raising concerns. Design A collective case study underpinned by implementation science.
Aidín McKinney, Donna Fitzsimons, Bronagh Blackwood, Jennifer McGaughey   +3 more
wiley   +1 more source

Medication overuse headache and its specific clinical markers

Headache Medicine, 2016
Introduction: Clinical markers of medication overuse headache (MOH) are based on headache classification developed by the International Headache Society (IHS).
Nelson U. Barrientos, Philippe G. Salles , Anna S. Milán , Paulina C. Meza , Raúl P. Juliet , Alan Rapoport   +5 more
doaj   +1 more source

Medication Overuse Headache

Physical Medicine and Rehabilitation Clinics of North America
Medication overuse headache (MOH) is defined as a new or worsening headache occurring more than 15 days a month in people with a pre-existing primary headache that develops as a result of regular overuse of acute headache treatments. MOH is a common secondary headache disorder with an estimated prevalence of 1% to 5%.
Aleksenko D, Lui F, Sánchez-Manso JC.
europepmc   +3 more sources

Satire and Silence Under Authoritarian Rule: Cotton and Pesticide Perceptions in Tajikistan

Journal of Agrarian Change, EarlyView.
ABSTRACT Over the past 70 years, agricultural chemicals have become a mainstay of cotton farming in Central Asia. This growing reliance on agrochemicals has not remained uncontested. This article analyses the politics of pesticides in Soviet and post‐Soviet Tajikistan by examining how, and to what extent, pesticides have featured in graphic satire, an ...
Irna Hofman, Flora Roberts
wiley   +1 more source

Cancer co‐medication quality in older patients with polypharmacy: A large randomized trial testing a medication review versus usual care

Journal of Internal Medicine, EarlyView.
Abstract Background Evidence from randomized controlled trials (RCTs) testing medication reviews in geriatric oncology is sparse. Methods We conducted a single‐blinded RCT in ten rehabilitation clinics across Germany. Patients with common cancers, aged ≥ 65 years, and polypharmacy (regularly ≥ five drugs) were randomly allocated in equal proportions to
Miriam Degen, Annette Kopp‐Schneider, Tomislav Vlaski, Sigrid Carlsson, Peter Hallermann, Ludmilla Jewlanowa, Jana Barinoff, Valentin Goede, Christian Lüders, Thomas Kiefer‐Trendelenburg, Diana Lüftner, Jasmin Doll, Jürgen Wagner, Birgit Leibbrand, Hermann Brenner, Ben Schöttker   +15 more
wiley   +1 more source